Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04955730 · ClinicalTrials.gov registry record · Phase 2

NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies

A Phase 2 study of Surgical Wound Infection, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
Phase 2
Development phase
290
Enrollment target
1
Study location

NCT04955730 is a Phase 2 study of Surgical Wound Infection that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 290 participants, below the 892-participant average among 8 other Surgical Wound Infection trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04955730, a Phase 2 study of Surgical Wound Infection, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
290 participants
Enrollment target
1
Study location

Study Summary

This randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections

Conditions Studied

Interventions

  • DEVICE Negative Pressure Wound Therapy

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 290 participants
Start Date 2021-08-05
Est. Completion 2026-03
Phase Phase 2

What the Registry Record Tells You About NCT04955730

The ClinicalTrials.gov registry entry for NCT04955730 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 892-participant average among 8 other Surgical Wound Infection trials with a reported enrollment target (67% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgical Wound Infection appearing as the primary indexed condition, and to 1 intervention - of which Negative Pressure Wound Therapy is the first listed.

NCT04955730 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04955730 about?

NCT04955730 is a clinical study titled "NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies". This randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections

What is the current status of trial NCT04955730?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 290 participants. The study started on 2021-08-05. Estimated completion is 2026-03.

What conditions does trial NCT04955730 study?

This clinical trial studies the following conditions: Surgical Wound Infection.

What interventions are being tested in trial NCT04955730?

The interventions under investigation include: Negative Pressure Wound Therapy (DEVICE).

Who is sponsoring clinical trial NCT04955730?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04955730 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Wound Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.